Explore

Your selections: Drugs
And other neuroscience news for the week of November 2, 2020.
  • BrainFacts/SfN
David Julius and Ardem Patapoutian discuss their research on sensory systems that won them the 2020 Kavli Prize in Neuroscience.
  • BrainFacts/SfN
These were the top neuroscience stories for the week of September 14, 2020.
  • BrainFacts/SfN
Opiate drugs derived from poppy seeds hijack the brain’s natural opioid system.
  • BrainFacts/SfN
For years, anecdotal reports suggested microdosing can improve mood and reduce depression and anxiety. Now, scientists are trying to figure out whether it’s all hype, a salve for our unhappiness, or something in between.
  • BrainFacts/SfN
Itch, once thought of as a milder form of pain, is now investigated as its own condition with potential treatment on the horizon.
  • BrainFacts/SfN
As genetic sequencing becomes more affordable and the number of families seeking answers grow, neuroscientists make a discovery that could lead to treatments.
  • BrainFacts/SfN
Around one in 10,000 infants are born with SMA. Research funding and patient advocacy efforts helped push treatment into existence.
  • BrainFacts/SfN
Chance observations in the 1950s prompted scientists to hypothesize that low neurotransmitter levels cause depression. That thinking has unraveled.
  • Knowable Magazine
The fast-acting drug offers a new way to treat depression and fathom its origins. Recent approval of a nasal spray promises to expand access, but much remains unknown.
  • Knowable Magazine
In response to the rising opioid epidemic, neuroscience researchers worldwide are working to develop new treatments for chronic pain.
  • BrainFacts/SfN
Learn about the reward prediction error hypothesis as it applies to addiction and reward cues in thebrain.
  • BrainFacts/SfN
  • 5 min